[{"NetIncomeLoss_3_Q3_USD":11433000.0,"CostOfGoodsAndServicesSoldAmortization_3_Q3_USD":5126000.0,"PaymentsToAcquireInvestments_3_Q3_USD":1000000.0,"Depreciation_1_Q3_USD":1500000.0,"Depreciation_3_Q3_USD":4500000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-1275000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q3_USD":16000000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-10677000.0,"InventoryFinishedGoods_0_Q3_USD":59535000.0,"InterestPaidNet_3_Q3_USD":1065000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":44575000.0,"GainLossOnSaleOfPropertyPlantEquipment_3_Q3_USD":1516000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q3_USD":15066000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":33638000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":33649000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":12853000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":40316000.0,"ProvisionForDoubtfulAccounts_3_Q3_USD":273000.0,"CostOfGoodsAndServicesSoldAmortization_1_Q3_USD":1642000.0,"InventoryRawMaterialsAndSupplies_0_Q3_USD":21349000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q3_USD":10000.0,"GoodwillForeignCurrencyTranslationGainLoss_3_Q3_USD":-2006000.0,"UnrecognizedTaxBenefitsPeriodIncreaseDecrease_1_Q3_USD":0.0,"Assets_0_Q3_USD":561251000.0,"ProceedsFromOtherDebt_3_Q3_USD":0.0,"CommonStockSharesIssued_0_Q3_shares":34152623.0,"IncomeTaxesPaidNet_3_Q3_USD":3172000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q3_USD":2649000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":0.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":0.0,"ProvisionForDoubtfulAccounts_1_Q3_USD":-14000.0,"SellingAndMarketingExpense_1_Q3_USD":28260000.0,"ContractWithCustomerLiability_0_Q3_USD":30277000.0,"RestructuringCharges_1_Q3_USD":142000.0,"RestructuringCharges_3_Q3_USD":469000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q3_shares":227000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_3_Q3_shares":228000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_1_Q3_USD":0.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_3_Q3_USD":119000.0,"AssetsCurrent_0_Q3_USD":261671000.0,"SellingAndMarketingExpense_3_Q3_USD":86719000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"ProductWarrantyAccrual_0_Q3_USD":4513000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_3_Q3_USD":612000.0,"Revenues_3_Q3_USD":344782000.0,"EffectOfExchangeRateOnCashAndCashEquivalents_3_Q3_USD":-5272000.0,"CommonStockValue_0_Q3_USD":350457000.0,"NumberOfReportableSegments_3_Q3_segment":1.0,"IncreaseDecreaseInDeferredRevenue_3_Q3_USD":4629000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":1924000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":4292000.0,"AccountsReceivableNetCurrent_0_Q3_USD":97370000.0,"Revenues_1_Q3_USD":113877000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-229000.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":-822000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":33865000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":33877000.0,"FinanceLeasePrincipalPayments_3_Q3_USD":326000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q3_USD":17837000.0,"EarningsPerShareBasic_3_Q3_USD":0.34,"EarningsPerShareBasic_1_Q3_USD":0.17,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q3_USD":177555000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-497000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q3_USD":-3517000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":21337000.0,"ForeignCurrencyTransactionGainLossBeforeTax_3_Q3_USD":-1288000.0,"Liabilities_0_Q3_USD":138729000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":7370000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":68779000.0,"OtherAssetsNoncurrent_0_Q3_USD":17606000.0,"AmortizationOfIntangibleAssets_1_Q3_USD":3681000.0,"AmortizationOfIntangibleAssets_3_Q3_USD":11497000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":5229000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":2056000.0,"IntangibleAssetsGrossExcludingGoodwill_0_Q3_USD":267368000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":3799000.0,"ProductWarrantyAccrualPayments_1_Q3_USD":798000.0,"ProductWarrantyAccrualPayments_3_Q3_USD":2205000.0,"CostsAndExpenses_1_Q3_USD":44487000.0,"CostsAndExpenses_3_Q3_USD":139019000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":-57968000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q3_pure":0.257,"EffectiveIncomeTaxRateContinuingOperations_3_Q3_pure":0.273,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q3_USD":-568000.0,"IncreaseDecreaseInInventories_3_Q3_USD":-3655000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":14267000.0,"OtherComprehensiveIncomeLossNetOfTax_3_Q3_USD":-7634000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":9946000.0,"NonoperatingIncomeExpense_3_Q3_USD":-3355000.0,"AccountsPayableCurrent_0_Q3_USD":28322000.0,"DeferredRevenueCurrent_0_Q3_USD":25737000.0,"LiabilitiesCurrent_0_Q3_USD":103801000.0,"InventoryWorkInProcess_0_Q3_USD":2746000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":33638000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":33649000.0,"RepaymentsOfDebt_3_Q3_USD":57000000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":51212000.0,"ProductWarrantyExpense_3_Q3_USD":1523000.0,"ProceedsFromSaleOfPropertyPlantAndEquipment_3_Q3_USD":2674000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":7497000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":15725000.0,"MarketDataRevenue_1_Q3_USD":113877000.0,"MarketDataRevenue_3_Q3_USD":344782000.0,"Goodwill_0_Q3_USD":149293000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":32024000.0,"NonoperatingIncomeExpense_1_Q3_USD":-1048000.0,"InterestExpense_3_Q3_USD":1655000.0,"InterestExpense_1_Q3_USD":332000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":23977000.0,"NetIncomeLoss_1_Q3_USD":5573000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":22837000.0,"PropertyPlantAndEquipmentGrossPeriodIncreaseDecrease_3_Q3_USD":805000.0,"ShortTermBorrowings_0_Q3_USD":0.0,"ProceedsFromPaymentsForOtherFinancingActivities_3_Q3_USD":-1254000.0,"InventoryNoncurrent_0_Q3_USD":12085000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_0_Q3_USD":5287000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q3_USD":13144000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q3_USD":9826000.0,"FiniteLivedIntangibleAssetsNet_0_Q3_USD":71580000.0,"IncreaseDecreaseInDeferredIncomeTaxes_3_Q3_USD":-1060000.0,"GrossProfit_1_Q3_USD":67748000.0,"GrossProfit_3_Q3_USD":200637000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_1_Q3_USD":-3517000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_3_Q3_USD":-7844000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q3_USD":73602000.0,"LongTermDebtNoncurrent_0_Q3_USD":0.0,"ImpairmentChargeOnReclassifiedAssets_3_Q3_USD":443000.0,"ContractWithCustomerLiabilityRevenueRecognized_3_Q3_USD":17535000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q3_USD":12532000.0,"EarningsPerShareDiluted_1_Q3_USD":0.16,"AllocatedShareBasedCompensationExpense_3_Q3_USD":8271000.0,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":561251000.0,"PreferredStockValue_0_Q3_USD":0.0,"FiniteLivedIntangibleAssetsGross_0_Q3_USD":265346000.0,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":25700000.0,"InventoryNet_0_Q3_USD":71545000.0,"PaymentsForRepurchaseOfCommonStock_3_Q3_USD":0.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":2649000.0,"AllowanceForDoubtfulAccountsReceivable_0_Q3_USD":5980000.0,"OperatingIncomeLoss_3_Q3_USD":19080000.0,"CommonStockSharesAuthorized_0_Q3_shares":120000000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":3878000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_1_Q3_USD":0.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_3_Q3_USD":-91000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"DeferredIncomeTaxAssetsNet_0_Q3_USD":26296000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.001,"OperatingIncomeLoss_1_Q3_USD":8545000.0,"ShareBasedCompensation_3_Q3_USD":8271000.0,"FinanceLeaseRightOfUseAsset_0_Q3_USD":2432000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":54861000.0,"EarningsPerShareDiluted_3_Q3_USD":0.34,"CommonStockSharesOutstanding_0_Q3_shares":34152623.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":428000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":-13303000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":82742000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0_Q3_USD":2414000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q3_USD":5980000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":2949000.0,"ImpairmentOfIntangibleAssetsFinitelived_3_Q3_USD":0.0,"ContractWithCustomerLiabilityNoncurrent_0_Q3_USD":4600000.0,"AllowanceForDoubtfulAccountsReceivableWriteOffs_1_Q3_USD":136000.0,"AllowanceForDoubtfulAccountsReceivableWriteOffs_3_Q3_USD":506000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":17732000.0,"SalesTypeAndDirectFinancingLeasesProfitLoss_3_Q3_USD":-3000.0,"OperatingExpenses_1_Q3_USD":59203000.0,"OperatingExpenses_3_Q3_USD":181557000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q3_USD":5300000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":5167000.0,"StockholdersEquity_0_Q3_USD":422522000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":42556000.0,"Ticker":"NTUS","CIK":"878526","name":"NATUS MEDICAL INC","OfficialName":"Natus Medical Incorporated Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"3","uom":"USD","footnote":"nan","Market Cap":"1152673159.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20211105"}]